Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: A systematic review and meta-analysis
EndocrinologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Diabetes research and clinical practice
- Publicado em
- 6 nov 2022
- Citações
- 21
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: A systematic review and meta-analysis
Athina Stamati, Thomas Karagiannis, Apostolos Tsapas, Athanasios Christoforidis
Descritores MeSH
- Diabetes Mellitus, Type 1
- Hypoglycemia
- Hypoglycemic Agents
- Insulin
- Insulin, Short-Acting
- Adult
- Insulin, Regular, Human
- Humans
Veja também
Estudos relacionados
- (Ultra-)short-acting insulin analogues for adults with type 1 diabetes mellitus on multiple daily injections: a network meta-analysis
- Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a systematic review with meta-analysis and trial sequential analysis
- Efficacy and Safety of Inhalational Insulin Compared With Rapid-Acting Insulin Analogs: A Systematic Review and Meta-Analysis
- A comparison of ultra-rapid and rapid insulin in automated insulin delivery for type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials